Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Diethyl Ether | HCID 3283 | — |
| Reactant | Boron trifluoride | HCID 6356 | — |
| Reactant | Triethylsilane | HCID 12052 | — |
| Reactant | HCID 86664046 | HCID 86664046 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Solvent | Sodium Bicarbonate | HCID 516892 | — |
| Product | HCID 86664047 | HCID 86664047 | 73% |
Reaction Steps
Ethyl 1-[5-[7-(dimethoxymethyl)-2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyrimidin-2-yl]-4-ethyl-piperidine-4-carboxylate (35 mg, 0.063 mmol) was dissolved in DCM (2 mL), cooled to 0° C. and treated sequentially with Et3SiH (50 μL, 0.313 mmol) and BF3:OEt2 (15 μL, 0.119 mmol) and the mixture stirred for 10 mins then allowed to warm to rt. After 40 mins additional Et3SiH (50 μL, 0.313 mmol) was added at rt followed by BF3:OEt2 (15 μL, 0.119 mmol) and the mixture stirred for 2.5 h after which time the reaction was diluted with sat. NaHCO3 (aq), extracted with DCM (3×), dried and the solvent evaporated to yield the crude product (31.7 mg). The crude product was purified on 12 g SiO2 using EtOAc/Cyclohexane gradient 0-0% 3CV, 0-100% 30CV, 100-100% 5CV to yield the desired compound (22.3 mg, 73%). 1H NMR (CDCl3) δ 8.59 (s, 2H), 7.79 (d, J=1.2 Hz, 1H), 7.25 (d, J=0.9 Hz, 1H), 4.66 (s, 2H), 4.53 (dt, J=13.7, 3.5 Hz, 2H), 4.22 (q, J=7.1 Hz, 2H), 3.51-3.40 (m, 2H), 3.38 (s, 3H), 3.22-3.07 (m, 2H), 2.23 (d, J=13.4 Hz, 2H), 1.59 (q, J=7.5 Hz, 2H), 1.48-1.43 (m, 2H), 1.29 (dd, J=10.0, 4.1 Hz, 6H), 0.85 (t, J=7.5 Hz, 3H). MS: 527.15 [M+H]+
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09181234B2 |
|---|
| Source dataset | uspto-grants-2015_11 |
|---|
| ORD ID | ord-8aa8cd3b50e3498bbfa953f59d5996a4 |
|---|
| Source note | uspto-grants-2015_11 |
|---|